Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway.
Publication Title
Clin Epigenetics
Document Type
Article
Publication Date
12-27-2024
Keywords
california; jwci; sjci; santa monica
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
DOI
10.1186/s13148-024-01797-6
COinS